Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|July 5, 2021
CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory ToxicitiesJoseph W Fischer, Nirjal Bhattarai
Critical Reviews in Biochemistry and Molecular Biology|January 19, 2017
CircRNAs: a regulator of cellular stressJoseph W Fischer, Anthony K L Leung
Current Opinion in Clinical Nutrition and Metabolic Care|December 5, 2014
Proline metabolism and cancer: emerging links to glutamine and collagenJames M Phang, Wei Liu, Chad N Hancock, et al.
Molecular Cell|February 5, 2020
Structure-Mediated RNA Decay by UPF1 and G3BP1Joseph W Fischer, Veronica F Busa, Yue Shao, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 21, 2021
TCR-independent Activation in Presence of a Src-family Kinase Inhibitor Improves CAR-T Cell Product AttributesGauri Lamture, Alan Baer, Joseph W Fischer, et al.
Scientific Reports|November 25, 2015
Proline biosynthesis augments tumor cell growth and aerobic glycolysis: involvement of pyridine nucleotidesWei Liu, Chad N Hancock, Joseph W Fischer, et al.
International Journal of Cancer|February 11, 2012
Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-κB signaling pathwaysBilal Bin Hafeez, Mohammad Sarwar Jamal, Joseph W Fischer, et al.
Carcinogenesis|September 15, 2012
Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markersBilal Bin Hafeez, Weixiong Zhong, Ala Mustafa, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 29, 2015
Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition MarkersBilal Bin Hafeez, Joseph W Fischer, Ashok Singh, et al.
Pageof 2